Bioqual (OTCMKTS:BIOQ) Shares Down 0.5% – What’s Next?

Bioqual Inc. (OTCMKTS:BIOQ)’s share price fell 0.5% during mid-day trading on Monday . The stock traded as low as $35.01 and last traded at $35.01. 200 shares traded hands during mid-day trading, an increase of 3,233% from the average session volume of 6 shares. The stock had previously closed at $35.20.

Bioqual Stock Down 0.5%

The firm has a fifty day simple moving average of $37.14 and a 200-day simple moving average of $37.94. The company has a market capitalization of $31.16 million, a P/E ratio of -32.42 and a beta of -0.17.

Bioqual (OTCMKTS:BIOQ) last announced its quarterly earnings results on Tuesday, April 21st. The company reported ($0.84) earnings per share (EPS) for the quarter. The business had revenue of $9.84 million during the quarter. Bioqual had a negative return on equity of 2.67% and a negative net margin of 2.27%.

Bioqual Company Profile

Bioqual, Inc is a U.S.-based contract research organization specializing in preclinical immunology and pharmacology services for the biopharmaceutical industry. The company offers a range of in vivo and in vitro testing solutions designed to support vaccine development, immuno-oncology programs and other therapeutic modalities. Bioqual’s service portfolio encompasses assay development, safety and efficacy studies, biomarker analysis and specialized immunogenicity assessments.

Leveraging proprietary humanized animal models and nonhuman primate research platforms, Bioqual helps clients evaluate biological activity, toxicity and pharmacokinetics of investigational compounds.